Dexamethasone in hospitalized patients with Covid-19 — preliminary report
<p><strong>BACKGROUND</strong></p> <p>Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.</p> <p><stro...
Main Authors: | Horby, P, Lim, WS, Emberson, J, Mafham, M, Bell, JL, Linsell, L, Staplin, N, Juszczak, E, Haynes, R, Landray, M |
---|---|
Other Authors: | RECOVERY Collaborative Group |
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2020
|
Similar Items
-
Effect of hydroxychloroquine in hospitalized patients with COVID-19
by: Horby, P, et al.
Published: (2020) -
Effect of hydroxychloroquine in hospitalized patients with COVID-19 - preliminary report
by: Linsell, L, et al.
Published: (2020) -
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Mafham, M, et al.
Published: (2021) -
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Landray, M, et al.
Published: (2022) -
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
by: Horby, P, et al.
Published: (2021)